Literature DB >> 33159254

iCDA-CMG: identifying circRNA-disease associations by federating multi-similarity fusion and collective matrix completion.

Qiu Xiao1,2, Jiancheng Zhong3, Xiwei Tang4, Jiawei Luo5.   

Abstract

Circular RNAs (circRNAs) are a special class of non-coding RNAs with covalently closed-loop structures. Studies prove that circRNAs perform critical roles in various biological processes, and the aberrant expression of circRNAs is closely related to tumorigenesis. Therefore, identifying potential circRNA-disease associations is beneficial to understand the pathogenesis of complex diseases at the circRNA level and helps biomedical researchers and practitioners to discover diagnostic biomarkers accurately. However, it is tremendously laborious and time-consuming to discover disease-related circRNAs with conventional biological experiments. In this study, we develop an integrative framework, called iCDA-CMG, to predict potential associations between circRNAs and diseases. By incorporating multi-source prior knowledge, including known circRNA-disease associations, disease similarities and circRNA similarities, we adopt a collective matrix completion-based graph learning model to prioritize the most promising disease-related circRNAs for guiding laborious clinical trials. The results show that iCDA-CMG outperforms other state-of-the-art models in terms of cross-validation and independent prediction. Moreover, the case studies for several representative cancers suggest the effectiveness of iCDA-CMG in screening circRNA candidates for human diseases, which will contribute to elucidating the pathogenesis mechanisms and unveiling new opportunities for disease diagnosis and targeted therapy.

Entities:  

Keywords:  Circular RNA (circRNA); Disease circRNA prediction; Multi-similarity fusion; circRNA–disease associations

Mesh:

Substances:

Year:  2020        PMID: 33159254     DOI: 10.1007/s00438-020-01741-2

Source DB:  PubMed          Journal:  Mol Genet Genomics        ISSN: 1617-4623            Impact factor:   3.291


  36 in total

Review 1.  Similarity-based machine learning methods for predicting drug-target interactions: a brief review.

Authors:  Hao Ding; Ichigaku Takigawa; Hiroshi Mamitsuka; Shanfeng Zhu
Journal:  Brief Bioinform       Date:  2013-08-11       Impact factor: 11.622

Review 2.  Circular RNA and miR-7 in cancer.

Authors:  Thomas B Hansen; Jørgen Kjems; Christian K Damgaard
Journal:  Cancer Res       Date:  2013-09-06       Impact factor: 12.701

3.  Circular RNA circPVT1 Promotes Proliferation and Invasion Through Sponging miR-125b and Activating E2F2 Signaling in Non-Small Cell Lung Cancer.

Authors:  Xiuyuan Li; Zenglei Zhang; Hua Jiang; Qiang Li; Ruliang Wang; Hongliang Pan; Yingying Niu; Fenghai Liu; Hongmei Gu; Xingjun Fan; Jinxia Gao
Journal:  Cell Physiol Biochem       Date:  2018-12-07

4.  Circular RNAs throw genetics for a loop.

Authors:  Heidi Ledford
Journal:  Nature       Date:  2013-02-28       Impact factor: 49.962

5.  Predicting microRNA-disease associations using label propagation based on linear neighborhood similarity.

Authors:  Guanghui Li; Jiawei Luo; Qiu Xiao; Cheng Liang; Pingjian Ding
Journal:  J Biomed Inform       Date:  2018-05-12       Impact factor: 6.317

6.  Graph Regularized Nonnegative Matrix Factorization for Data Representation.

Authors:  Deng Cai; Xiaofei He; Jiawei Han; Thomas S Huang
Journal:  IEEE Trans Pattern Anal Mach Intell       Date:  2010-12-23       Impact factor: 6.226

7.  circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a.

Authors:  Rongfang He; Peng Liu; Xiaoming Xie; Yujuan Zhou; Qianjin Liao; Wei Xiong; Xiaoling Li; Guiyuan Li; Zhaoyang Zeng; Hailin Tang
Journal:  J Exp Clin Cancer Res       Date:  2017-10-16

8.  Integrating random walk with restart and k-Nearest Neighbor to identify novel circRNA-disease association.

Authors:  Xiujuan Lei; Chen Bian
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

9.  Predicting circRNA-Disease Associations Based on Improved Collaboration Filtering Recommendation System With Multiple Data.

Authors:  Xiujuan Lei; Zengqiang Fang; Ling Guo
Journal:  Front Genet       Date:  2019-09-25       Impact factor: 4.599

10.  Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis.

Authors:  Xiao-Yong Huang; Peng-Fei Zhang; Chuan-Yuan Wei; Rui Peng; Jia-Cheng Lu; Chao Gao; Jia-Bing Cai; Xuan Yang; Jia Fan; Ai-Wu Ke; Jian Zhou; Guo-Ming Shi
Journal:  Mol Cancer       Date:  2020-05-19       Impact factor: 27.401

View more
  4 in total

Review 1.  Circular RNAs and complex diseases: from experimental results to computational models.

Authors:  Chun-Chun Wang; Chen-Di Han; Qi Zhao; Xing Chen
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 11.622

Review 2.  Promising Roles of Circular RNAs as Biomarkers and Targets for Potential Diagnosis and Therapy of Tuberculosis.

Authors:  Yifan Huang; Ying Li; Wensen Lin; Shuhao Fan; Haorong Chen; Jiaojiao Xia; Jiang Pi; Jun-Fa Xu
Journal:  Biomolecules       Date:  2022-09-04

Review 3.  Function and Clinical Significance of Circular RNAs in Thyroid Cancer.

Authors:  Xuelin Yao; Qiu Zhang
Journal:  Front Mol Biosci       Date:  2022-07-22

Review 4.  A Survey on Computational Methods for Investigation on ncRNA-Disease Association through the Mode of Action Perspective.

Authors:  Dongmin Bang; Jeonghyeon Gu; Joonhyeong Park; Dabin Jeong; Bonil Koo; Jungseob Yi; Jihye Shin; Inuk Jung; Sun Kim; Sunho Lee
Journal:  Int J Mol Sci       Date:  2022-09-29       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.